3900
Published on November 5, 2020
Bangladesh has signed a memorandum of understanding (MoU) with the Serum Institute of India (SII) and its counterpart Beximco Pharmaceuticals Ltd to receive Covid-19 vaccines being developed by the Indian drug manufacturer.
“Serum will provide the 30 million doses of the vaccine in the first phase as it has been proven effective,” Health Minister Zahid Maleque while addressing the MoU signing ceremony at the ministry conference room in Dhaka on Thursday.
"The MoU is being signed on the condition that the vaccine will be taken only if cleared the World Health Organization," he added.
Indian High Commissioner Vikram K Doraiswami was aso present at the ceremony, reads a press release.
Once finally approved for human application, the SII will supply Covishield, the Indian version of Oxford-AtraZeneca's coronavirus vaccine, in phases, via Beximco Pharmaceuticals Ltd to Bangladesh, according to the MoU.
Source: Dhaka Tribune
This work is copyrighted and authorized by the Bangladesh Awami League. You may download, display, print and re-produce this material in unaltered form only (retaining this notice)for your personal, non-commercial use or use within your organization.
